• 1,3-Beta-D-Glucan (Fungitell® ß-D Glucan), Bronchial Wash
  • Targeted Gene Mutation Panel, Solid Organ Neoplasm (PancreaSeq)
  • Cytochrome P450 2C9 (CYP2C9) Genotyping
  • Factor XIII (F13A1) V34L Genetic Variation Analysis
  • Bartonella Antibody, IgG and IgM, Serum
  • Kappa and Lambda Free Light Chains, Quantitative, Urine
  • Bruton Tyrosine Kinase (BTK) Gene Mutation Analysis
  • Galactocerebrosidase Activity, Blood
  • Biopsy, Different Sites
  • Jo 1 Antibody, IgG
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Circulating Tumor Cells (CTC), Colon Cancer
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Circulating Tumor Cells (CTC), Colon Cancer
Medical Test

Turnaround Time
Access to Circulating Tumor Cells (CTC), Colon Cancer is restricted.
Loading...